Both Host and Pathogen Factors Predispose to Escherichia coli Urinary-Source Bacteremia in Hospitalized Patients

High-Throughput Identification of Chemical Inhibitors of E. coli Group 2 Capsule Biogenesis as Anti-Virulence Agents

(2010) Carlos C. Goller et al.   PLoS One

Post-Void Residual Urine as a Predictor of Urinary Tract Infection—Is There a Cutoff Value in Asymptomatic Men?

(2009) Matthias May et al.   JOURNAL OF UROLOGY

Quantitative Metabolomics Reveals an Epigenetic Blueprint for Iron Acquisition in Uropathogenic Escherichia coli

(2009) Jeffrey P. Henderson et al.   PLoS Pathogens

Virulence factors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin

(2008) M. Rijavec et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Comparison of laboratory-based and phylogenetic methods to distinguish between Haemophilus influenzae and H. haemolyticus

(2008) Sara A. Sandstedt et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Residual Urinary Volume and Urinary Tract Infection—When are They Linked?

(2008) José Carlos I. Truzzi et al.   JOURNAL OF UROLOGY

Capsular polysaccharide and the O-specific antigen impede antibody binding: A potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine

(2008) Thomas A. Russo et al.   VACCINE

The biology and future prospects of antivirulence therapies

(2007) Lynette Cegelski et al.   NATURE REVIEWS MICROBIOLOGY